KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 293 filers reported holding KARUNA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $54,461,353 | -22.4% | 322,085 | -0.4% | 0.09% | -19.1% |
Q2 2023 | $70,141,868 | +19.5% | 323,458 | +0.1% | 0.11% | +11.1% |
Q1 2023 | $58,680,801 | +15.1% | 323,061 | +24.5% | 0.10% | +4.2% |
Q4 2022 | $51,003,932 | -1.4% | 259,562 | +12.9% | 0.10% | -5.9% |
Q3 2022 | $51,714,000 | – | 229,913 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARCH Venture Management, LLC | 2,912,872 | $369,323,000 | 52.78% |
Pivotal bioVenture Partners Investment Advisor LLC | 852,708 | $108,115,000 | 51.15% |
Sofinnova Investments, Inc. | 1,953,077 | $247,631,000 | 18.79% |
Nan Fung Group Holdings Ltd | 234,811 | $29,772,000 | 14.12% |
Sands Capital Ventures, LLC | 267,895 | $33,966,000 | 7.10% |
Logos Global Management LP | 340,000 | $43,109,000 | 5.59% |
DAFNA Capital Management LLC | 82,053 | $10,403,000 | 2.71% |
Ghost Tree Capital, LLC | 60,000 | $7,607,000 | 1.65% |
CATALYST PRIVATE WEALTH, LLC | 24,976 | $3,167,000 | 1.58% |
Eventide Asset Management | 748,000 | $94,839,000 | 1.49% |